Application of moutan bark derived carbon dots in preparation of medicine for treating myocarditis
CN119015343AActive Publication Date: 2024-11-26NANJING HOSPITAL OF TCM
Patent Information
- Application Number
- CN202411113196.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-14
Smart Images

Figure HDA0004992881910000011 
Figure HDA0004992881910000021 
Figure HDA0004992881910000022
Abstract
The invention discloses application of moutan bark derived carbon dots in preparation of a medicine for treating myocarditis. The moutan bark derived carbon dots (MCDs) obtained by high-temperature heating through a one-step hydrothermal method have good biocompatibility, show excellent ROS (reactive oxygen species) resistance in vivo and in vitro, and can remarkably remove OH, O2 <-> and < 1 > O2. The MCDs can effectively inhibit the oxidative damage and proinflammatory factor level of myocarditis cells and mice with acute myocarditis. The MCDs provided by the invention are easy to prepare and simple to synthesize, can improve the cardiac function of a mouse with acute myocarditis and effectively relieve myocardial damage, and provides a new technology and a new preparation for treating myocarditis.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Traditional Chinese medicinal formula for treating myocarditis, and preparation method thereof
CN107648487A
Carbon nanoparticles with blood cooling and hemostasis effects
CN115475143A
Preparation method and application of traditional Chinese medicine carbon quantum dots for improving mangiferin performance
CN116059382A
Preparation and application of cortex moutan nanoparticles
CN117679454A
Cited By
Application of moutan bark derived carbon dots in treatment of acute myelogenous leukemia
CN121796433A
Application of peony root-derived carbon dots in treatment of acute myeloid leukemia
CN121796433B
